Health Affairs November 3, 2025
Editor’s Note
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Articles in this topic offer timely analyses of regulatory, legislative, and judicial developments in health policy under the Trump-Vance Administration and the 119th Congress. Health Affairs Forefront alone reviews all submissions then selects, edits, and publishes them only if they meet Forefront’s editorial standards.
On October 30, 2025, a federal district court in Hawaii sided with physicians who challenged current restrictions on mifepristone, a medication approved by the Food and Drug Administration (FDA) for a quarter-century as safe and effective to terminate an early pregnancy. These restrictions,...
Today's Sponsors
Today's Sponsor